Group One Trading, L.P. Iveric Bio, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$18.67 - $24.56 $951,292 - $1.25 Million	-50,953 Reduced 96.75%	1,712 $41,000
Q4 2022 Feb 09, 2023	SELL	$17.24 - $23.95 $3.38 Million - $4.69 Million	-195,840 Reduced 78.81%	52,665 $1.13 Million
Q3 2022 Nov 09, 2022	BUY	$9.4 - $18.59 $2.34 Million - $4.62 Million	248,505 New	248,505 $4.46 Million
Q3 2021 Nov 12, 2021	SELL	$7.07 - $17.5 $17,766 - $43,977	-2,513 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$5.69 - $7.17 $14,298 - $18,018	2,513 New	2,513 $16,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.